Searched for
TYVALZI
Sun Pharma to invest $25 mn in Pharmazz Inc; raises stake to 22.7 pcSun Pharmaceutical Industries Ltd will invest up to USD 25 million in Pharmazz Inc, increasing its stake to 22.7%. This investment triggers...- Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in IndiaDr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The pa...
- Sun Pharma scouting for innovative therapies to boost India businessApproved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...
- Sun Pharma unit inks licensing pact with US-based firm to introduce drug to treat stroke"The Phase 3 clinical trial for Tyvalzi conducted in India demonstrated statistically and clinically meaningful improvement in neurological...
Load More